0001228924-20-000025.txt : 20200904 0001228924-20-000025.hdr.sgml : 20200904 20200904112556 ACCESSION NUMBER: 0001228924-20-000025 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200901 FILED AS OF DATE: 20200904 DATE AS OF CHANGE: 20200904 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sakys John CENTRAL INDEX KEY: 0001197710 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-11740 FILM NUMBER: 201161166 MAIL ADDRESS: STREET 1: MESA LABORATORIES, INC. STREET 2: 12100 W. 6TH AVENUE CITY: LAKEWOOD STATE: CO ZIP: 80228 FORMER NAME: FORMER CONFORMED NAME: SAKYS JOHN V DATE OF NAME CHANGE: 20021010 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MESA LABORATORIES INC /CO/ CENTRAL INDEX KEY: 0000724004 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL INSTRUMENTS FOR MEASUREMENT, DISPLAY, AND CONTROL [3823] IRS NUMBER: 840872291 STATE OF INCORPORATION: CO FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 12100 W 6TH AVE CITY: LAKEWOOD STATE: CO ZIP: 80228 BUSINESS PHONE: 3039878000 MAIL ADDRESS: STREET 1: 12100 W 6TH AVE CITY: LAKEWOOD STATE: CO ZIP: 80228 FORMER COMPANY: FORMER CONFORMED NAME: MESA LABORATORIES INC /CO DATE OF NAME CHANGE: 19951117 FORMER COMPANY: FORMER CONFORMED NAME: MESA MEDICAL INC DATE OF NAME CHANGE: 19921123 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2020-09-01 0 0000724004 MESA LABORATORIES INC /CO/ MLAB 0001197710 Sakys John MESA LABORATORIES, INC. 12100 W. 6TH AVENUE LAKEWOOD CO 80228 0 1 0 0 CFO Common Stock 2020-09-01 4 M 0 298 48.72 A 3698 D Common Stock 2020-09-01 4 S 0 298 250 D 3400 D Common Stock 2020-09-02 4 M 0 702 48.72 A 4102 D Common Stock 2020-09-02 4 S 0 702 251.42 D 3400 D Common Stock 2020-09-02 4 G 0 50 0 D 3350 D Non Qualified Stock Option 48.72 2020-09-01 4 X 0 298 0 D 2013-10-29 2022-10-29 Common Stock 298 38640 D Non Qualified Stock Option 48.72 2020-09-02 4 X 0 702 0 D 2013-10-29 2022-10-29 Common Stock 1000 37938 D 1/4 exercisable on each anniversary date of the 10/29/2012 grant date Sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 23,2020 John Sakys 2020-09-04